GUPTA LAB @ SJU
  • Home
  • Research
  • People
  • Publications & Patents
  • Capabilities
  • Gallery
  • NEWS
  • AAPS Chapter @SJU
  • Jarowski Symposium
  • CONTACT
  • Home
  • Research
  • People
  • Publications & Patents
  • Capabilities
  • Gallery
  • NEWS
  • AAPS Chapter @SJU
  • Jarowski Symposium
  • CONTACT

Innovation in Drug ​Discovery & Delivery

Congratulations to Mural Quadros for publishing her first research article on inhaled nanoemulsion for treating NSCLC • Congratulations to Dr Dnyandev for publishing his resarch article on nose to brain delivery of nintedanib for treatment of glioblastoma • Congratulations to Meghana Mokashi for being awarded for short top presentation at NERDG 2025 • Gupta Lab attends AAPS-NERDG 2025 • Gupta Lab attends St John's Student research conference 2025 • Gupta Lab celebrated Christmas with good food, fun games, and Dr. Gupta's delicious cooking! • Congratulations to Dr Kulkarni for publishing his research article on Doxorubicin loaded Hyrogels in Pharmaceutcial Research • Gupta lab attends AAPS 2024 in Utah!• Congratulations to Sajana Durve for presenting her poster at the AAPS Special Poster Collection • Gupta lab goes bowling! Check out the gallery to find the winner • Congratulations to Mimansa Goyal for successfully defending her PhD dissertation •

About Our Lab Group

At St. John’s University, our research lab specializes in non-invasive drug delivery, nanotechnology, oral delivery, 3D printing, targeted drug delivery, pulmonary hypertension, lung cancer, mesothelioma, drug discovery, and repurposing. Our team, comprising graduate and undergraduate students, is dedicated to developing non-invasive therapeutic delivery systems for various medical applications. 
​

Our current projects include enhancing FDA-approved drugs for lung cancer, developing targeted nanoparticles for Non-Small Cell Lung Cancer (NSCLC), creating inhalable carriers for pulmonary hypertension, and producing lipid-based inhalable carriers for cystic fibrosis-related pulmonary infections. We work on dry powder inhalation formulations to improve drug delivery efficiency and patient compliance and explore nose-to-brain delivery methods for treating brain diseases like glioblastoma. In addition to lung and brain delivery, we focus on oral drug delivery systems using FDA-approved polymers, lipids, and excipients to enhance drug solubility, dissolution, and permeability. We use software tools like GastroPlus for pharmacokinetic profile prediction and ZoomLab for formulation optimization. In vivo experiments are crucial for evaluating the efficacy, safety, and pharmacokinetics of our drug delivery systems in animal models. 

Our lab fosters interdisciplinary collaboration with groups and investigators in medicinal chemistry, pharmacology, and toxicology, strengthening our research capabilities and outcomes at St. John’s University.
 

Tweets

Tweets by GuptaLabSJU
Tweets by StJohnsU
Tweets by CRSScience
Tweets by NIH

Contact Us

Dr. Vivek Gupta, Ph.D.
Associate Professor, Pharmaceutical Sciences
College of Pharmacy & Health Sciences
718-990-3929 I Email I LinkedIn I Twitter


St. John’s University
SAH B-39B, 8000 Utopia Parkway, Queens, NY 11439
Lab phone: 718-990-6023
Picture
Proudly powered by Weebly